Hongjian Yang

1.2k total citations
59 papers, 635 citations indexed

About

Hongjian Yang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongjian Yang has authored 59 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 32 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongjian Yang's work include Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (11 papers) and Breast Lesions and Carcinomas (9 papers). Hongjian Yang is often cited by papers focused on Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (11 papers) and Breast Lesions and Carcinomas (9 papers). Hongjian Yang collaborates with scholars based in China, United States and Switzerland. Hongjian Yang's co-authors include Xingfei Yu, Yang Yu, Xiaofan Wu, Jiang‐Jiang Qin, You‐Lin Qiao, Jin‐Hu Fan, Xiaowen Ding, Qingkun Song, Rong Huang and Dehong Zou and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Hongjian Yang

58 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongjian Yang China	14	282	230	138	105	91	59	635
Antonella Pietragalla Italy	17	270 1.0×	119 0.5×	262 1.9×	87 0.8×	84 0.9×	36	693
Matilde Pensabene Italy	16	234 0.8×	141 0.6×	184 1.3×	161 1.5×	194 2.1×	35	597
Luis T. Campos United States	13	441 1.6×	140 0.6×	201 1.5×	77 0.7×	145 1.6×	29	726
Parvin F. Peddi United States	14	404 1.4×	152 0.7×	206 1.5×	45 0.4×	200 2.2×	30	661
Morihiko Kimura Japan	16	349 1.2×	204 0.9×	191 1.4×	145 1.4×	94 1.0×	47	698
Daniele Andreis Italy	16	396 1.4×	231 1.0×	250 1.8×	115 1.1×	200 2.2×	29	705
Anselmo Papa Italy	12	335 1.2×	160 0.7×	313 2.3×	53 0.5×	86 0.9×	25	675
Alessandro Villanucci Italy	14	209 0.7×	110 0.5×	189 1.4×	77 0.7×	128 1.4×	35	696
Ahmed Elkhanany United States	9	236 0.8×	170 0.7×	168 1.2×	40 0.4×	112 1.2×	25	527
Arrate Plazaola Spain	10	304 1.1×	282 1.2×	92 0.7×	121 1.2×	112 1.2×	26	501

Countries citing papers authored by Hongjian Yang

Since Specialization

Citations

This map shows the geographic impact of Hongjian Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjian Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjian Yang more than expected).

Fields of papers citing papers by Hongjian Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongjian Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjian Yang. The network helps show where Hongjian Yang may publish in the future.

Co-authorship network of co-authors of Hongjian Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongjian Yang. A scholar is included among the top collaborators of Hongjian Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongjian Yang. Hongjian Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yuting, et al.. (2024). Properties and hydration mechanism of foamed magnesium oxysulfate cement under acid modification. Case Studies in Construction Materials. 20. e03003–e03003. 2 indexed citations

Zhang, Qingyuan, Zhonghua Wang, Simon Li, et al.. (2024). A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer. BMC Cancer. 24(1). 1143–1143. 3 indexed citations

Ding, Yuqin, Ouchen Wang, Xiangming He, et al.. (2023). Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Oncology Research and Treatment. 46(7-8). 303–311. 6 indexed citations

Liu, Xiaozhen, et al.. (2023). Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study. BMC Cancer. 23(1). 361–361. 9 indexed citations

Yang, Qiuhui, et al.. (2023). Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer. Journal of Zhejiang University SCIENCE B. 24(12). 1123–1140. 13 indexed citations

Yang, Qiuhui, et al.. (2023). Advantages of contrast-enhanced ultrasound in the localization and diagnostics of sentinel lymph nodes in breast cancer. Journal of Zhejiang University SCIENCE B. 24(11). 985–997. 4 indexed citations

Zhang, Wei, Bailin Zhang, Jianjun He, et al.. (2021). Clinicopathological characteristics and treatment of young women with breast cancer in China: a nationwide multicenter 10-year retrospective study. Gland Surgery. 10(1). 175–185. 6 indexed citations

Xie, Xiaohong, Ouchen Wang, Yuqin Ding, et al.. (2021). Pyrotinib as neoadjuvant therapy for HER2+ breast cancer: A multicenter, randomized, controlled, phase II trial.. Journal of Clinical Oncology. 39(15_suppl). 574–574. 5 indexed citations

Zheng, Yurong, Xiaowen Ding, Dehong Zou, et al.. (2020). The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience. Cancer Biology & Therapy. 21(8). 675–687. 4 indexed citations

10.

Qiao, Enqi, Xingfei Yu, Lingyan Zhou, et al.. (2019). A Prospective Validation Cohort Study of a Prediction Model on Non-sentinel Lymph Node Involvement in Early Breast Cancer. Annals of Surgical Oncology. 27(5). 1653–1658. 5 indexed citations

11.

Wang, Chen, Qiang Huang, Yiwen Zhang, et al.. (2019). Effect of cimicifuga racemosa on menopausal syndrome caused by LHRH-a in breast cancer. Journal of Ethnopharmacology. 238. 111840–111840. 11 indexed citations

12.

Shao, Zhimin, Da Pang, Hongjian Yang, et al.. (2019). Abstract P6-17-17: Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY). Cancer Research. 79(4_Supplement). P6–17. 3 indexed citations

13.

Huang, Liang, Sheng Chen, Wentao Yang, et al.. (2015). Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial. Oncotarget. 6(21). 18683–18692. 20 indexed citations

14.

Yu, Xingfei, et al.. (2015). A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC). PLoS ONE. 10(8). e0136670–e0136670. 18 indexed citations

15.

Zhang, Xiping, Xiang Zhang, Hongjian Yang, et al.. (2015). [Treatment of Chemotherapy Related Leukocytopenia by Oral Administration of Multiple Leucogenic Drugs Combined with G-CSF: an Experimental Study].. PubMed. 35(7). 860–5. 2 indexed citations

16.

Song, Qingkun, Rong Huang, Jing Li, et al.. (2013). The Diverse Distribution of Risk Factors between Breast Cancer Subtypes of ER, PR and HER2: A 10-Year Retrospective Multi-Center Study in China. PLoS ONE. 8(8). e72175–e72175. 20 indexed citations

17.

Kong, Yanan, Lu Yang, Hailin Tang, et al.. (2013). A Nation-Wide Multicenter Retrospective Study of the Epidemiological, Pathological and Clinical Characteristics of Breast Cancer In Situ in Chinese Women in 1999 - 2008. PLoS ONE. 8(11). e81055–e81055. 10 indexed citations

18.

Zheng, Shan, Jing Li, Jin‐Hu Fan, et al.. (2012). The pathologic characteristics of breast cancer in China and its shift during 1999–2008: A national‐wide multicenter cross‐sectional image over 10 years. International Journal of Cancer. 131(11). 2622–2631. 60 indexed citations

19.

Su, Dan, et al.. (2012). Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy with Docetaxel-Containing Regimens in Locally Advanced Breast Cancer. Genetic Testing and Molecular Biomarkers. 16(7). 689–694. 23 indexed citations

20.

Sun, Caixing, et al.. (2011). Recursive partitioning analysis classification and graded prognostic assessment for non-small cell lung cancer patients with brain metastasis: A retrospective cohort study. Chinese Journal of Cancer Research. 23(3). 177–182. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact